Clinical Trials Update: Aug. 27, 2007
1816
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
310131
Aventis, part of the sanofi-aventis Group (EURONEXT: SAN), announced today that The New England Journal of Medicine has published the results of two landmark phase III studies, which demonstrate that Taxotere (docetaxel) Injection Concentrate-based
225429
2007 top science developments, tech flops, and vaporware...Szulik's parting words as Red Hat CEO...Sony Alpha A700 review...copyright tidbits...Toshiba 32nm deal with IBM
73400
Research and Markets (http://www.researchandmarkets.com/reports/c49927)  announces the addition of Frost & Sullivan's  new report Advances in Biomaterials for Medical Device Applications to  their offering.
549121
A U.S. Food and Drug Administration preliminary analysis found a level of heart-attack risk with GlaxoSmithKline Plc'sdiabetes drug Avandia similar to what was reported in a study earlier this week, the agency confirmed on Friday.
95097
NEW YORK -- The pharmaceutical industry yesterday said it plans to publish more data about clinical drug trials, despite skepticism about whether the initiative will increase transparency and improve drug safety.
552158
It can be incredibly difficult for patients to ferret out studies of experimental drugs that offer hope to threat their disease. There is no comprehensive database of ongoing clinical trials, but specialists offer advice for the search:
637665
roundup Plus: RIM touts BlackBerry with Wi-Fi...HP to sell Voltaire's InfiniBand switch...PC shipments up, but revenue less so, study says.
415778
NEW YORK, December 24  - The Food &amp; Drug Administration (FDA) announced yesterday that it planned to examine the various studies that link the usage of several painkillers with heightened cardiovascular risks, while recommending that
291930
Drug firm Merck &amp; Co. will present data this week showing that an experimental arthritis drug, Arcoxia, a treatment in the same class as its recently withdrawn Vioxx, showed no significant
749165
New studies shed some light on these controversial heart treatments, but many questions remain. What patients need to know.
315060
roundup Plus: IronPort spam shield gets steelier...Via brings PCI Express to AMD PCs...Rice lab makes nano parts less toxic.
606350
Abbott Laboratories filed a New Drug Application with the Food and Drug Administration for its drug Xinlay (atrasentan) to be used as a treatment for metastatic hormone-refractory prostate cancer.
217395
Pfizer Inc's experimental oral biotechnology drug axitinib demonstrated substantial anti-tumor activity in patients with advanced thyroid cancer in a small, mid-stage clinical trial, according to data released at a major cancer meeting on Saturday.
643185
FRIDAY, Sept. 15 (HealthDay News) -- Researchers may be able to determine the effectiveness of anti-angiogenic cancer drugs by measuring levels of a type of blood cell.
767081
Â· Lancet fast-tracks research sponsored by drug firm Â· Health advisers consider vaccinating older women
662969
Les donnÃ©es indiquent une augmentation de la rÃ©ponse sÃ©rologique, virologique et biochimique aprÃ¨s 144 semaines de traitement sur des patients naÃ¯fs atteints de l&#39;hÃ©patite B antigÃ¨ne positif.